Dapagliflozin improves the dysfunction of human umbilical vein endothelial cells (HUVECs) by downregulating high glucose/high fat-induced autophagy through inhibiting SGLT-2

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Diabetes and its Complications

Topics

Biology

Biochemistry

Medicine

Epidemiology

Internal Medicine

Show all topics

DOI

10.1016/j.jdiacomp.2024.108907